Erratum: Marked response to nab-paclitaxel in EGFR mutated lung neuroendocrine carcinoma: A case report: Erratum
Medicine (Baltimore)
.
2017 Jul 21;96(29):e7644.
doi: 10.1097/MD.0000000000007644.
eCollection 2017 Jul.
PMID:
31305693
PMCID:
PMC5521951
DOI:
10.1097/MD.0000000000007644
Abstract
[This corrects the article DOI: 10.1097/MD.0000000000006985.].
Publication types
Published Erratum